00239.HK
Pak Fah Yeow International Limited
HKSE · Healthcare · Drug Manufacturers - Specialty & Generic · HK
HKD 2.48
+1.02%Margins
Gross margin
63.8%
EBITDA margin
60.5%
EBIT margin
58.3%
Net margin
44.9%
FCF margin
20.5%
13.5%
Return on equity
11.3%
Return on assets
17.3%
Return on invested capital
0.26x
Asset turnover
HKD 45.6M
Cash from operations
HKD 1.28
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026